A Phase 1 Open-Label Study of the Safety of Intravenous Allogeneic Neonatal Mesenchymal Cells (nMSCs) in Young Adult (1A) and Pediatric (1B) Patients With Dilated Cardiomyopathy (DCM)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- William Mahle, MD
Emory University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Arthur M. Blank Hospital
Atlanta, Georgia, United States
William Mahle, MDRecruiting - Emory University Hospital
Atlanta, Georgia, United States
William Mahle, MDRecruiting - Grady Memorial Hospital
Atlanta, Georgia, United States
William Mahle, MDRecruiting - Hughes Spalding Children'S Hospital
Atlanta, Georgia, United States
William Mahle, MDRecruiting - Scottish Rite Children'S Hospital
Atlanta, Georgia, United States
William Mahle, MDRecruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 14 Jul 2025
- Primary completion
- 31 Jul 2027
- Completion
- 31 Jul 2027
- Last update posted
- 26 Jun 2026
- Registered enrollment
- 36
- Registry id
- NCT06464588
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.